Bnp Paribas Asset Management Holding S.A. Alnylam Pharmaceuticals, Inc. Transaction History

Bnp Paribas Asset Management Holding S.A.

$38.7 Billion
Q2 2024

A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 6,074 shares of ALNY stock, worth $1.67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,074

Previous 6,630 8.39%

Holding current value

$1.67 Million

Previous $991,000 48.94%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$143.31 - $247.0 $79,680 - $137,332	-556 Reduced 8.39%	6,074 $1.48 Million
Q1 2024 May 08, 2024	SELL	$146.51 - $198.2 $17.4 Million - $23.5 Million	-118,749 Reduced 94.71%	6,630 $991,000
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $1.85 Million - $2.41 Million	12,249 Added 10.83%	125,379 $24 Million
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $1.98 Million - $2.45 Million	11,588 Added 11.41%	113,130 $20 Million
Q2 2023 Aug 08, 2023	SELL	$185.01 - $212.05 $2.47 Million - $2.83 Million	-13,353 Reduced 11.62%	101,542 $19.3 Million
Q1 2023 May 08, 2023	SELL	$182.66 - $235.53 $2.18 Million - $2.82 Million	-11,952 Reduced 9.42%	114,895 $23 Million
Q4 2022 Feb 09, 2023	BUY	$185.53 - $241.31 $11.4 Million - $14.9 Million	61,583 Added 94.36%	126,847 $30.1 Million
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $1.65 Million - $2.76 Million	11,893 Added 22.28%	65,264 $13.1 Million
Q2 2022 Aug 04, 2022	BUY	$120.42 - $169.29 $1.08 Million - $1.52 Million	8,992 Added 20.26%	53,371 $7.78 Million
Q1 2022 May 12, 2022	BUY	$127.18 - $173.91 $5.48 Million - $7.5 Million	43,121 Added 3427.74%	44,379 $7.25 Million
Q4 2021 Feb 09, 2022	SELL	$159.56 - $209.29 $9.09 Million - $11.9 Million	-56,992 Reduced 97.84%	1,258 $213,000
Q3 2021 Nov 08, 2021	BUY	$169.75 - $207.73 $1.12 Million - $1.37 Million	6,595 Added 12.77%	58,250 $11 Million
Q2 2021 Aug 05, 2021	SELL	$128.63 - $176.89 $3.09 Million - $4.25 Million	-24,006 Reduced 31.73%	51,655 $8.76 Million
Q1 2021 May 05, 2021	BUY	$126.83 - $175.69 $1.87 Million - $2.59 Million	14,714 Added 24.14%	75,661 $10.7 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $1.24 Million - $1.48 Million	10,087 Added 19.83%	60,947 $7.92 Million
Q3 2020 Nov 09, 2020	BUY	$121.19 - $165.49 $338,968 - $462,875	2,797 Added 5.82%	50,860 $7.41 Million
Q2 2020 Aug 04, 2020	SELL	$104.21 - $156.44 $658,086 - $987,918	-6,315 Reduced 11.61%	48,063 $7.12 Million
Q1 2020 May 12, 2020	BUY	$93.12 - $133.99 $5.06 Million - $7.29 Million	54,378 New	54,378 $5.92 Million
Q4 2019 Feb 11, 2020	SELL	$74.51 - $124.23 $186,424 - $310,823	-2,502 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$70.9 - $87.82 $177,391 - $219,725	2,502 New	2,502 $201,000

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.

Account

Bnp Paribas Asset Management Holding S.A. Alnylam Pharmaceuticals, Inc. Transaction History